Press "Enter" to skip to content

New patent for Astellas drug CRESEMBA

1
Copyright © DrugPatentWatch. Originally published at New patent for Astellas drug CRESEMBA

Annual Drug Patent Expirations for CRESEMBA
Annual Drug Patent Expirations for CRESEMBA

Cresemba is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. There are two patents protecting this drug.

CRESEMBA drug price trends.

This drug has twenty-two patent family members in nineteen countries.

The generic ingredient in CRESEMBA is isavuconazonium sulfate. One supplier is listed for this compound. Additional details are available on the isavuconazonium sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astellas drug CRESEMBA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!